Change in Preferred Drug List Status for Generic Sildenafil Oral Suspension As Of Sept. 25, 2024
Published on
The manufacturer of the brand name Revatio oral suspension products discontinued them on Aug. 16, 2024. Due to this discontinuation, HHSC removed the non-preferred status from the generic sildenafil oral suspension products on the preferred drug list (PDL). The preferred status of brand name Revatio oral suspension products will not change, allowing pharmacies to use the existing stock of these medications.
HHSC removed the non-preferred status for the drugs in the table below effective Sept. 25, 2024. These changes allow the authorized generic sildenafil oral suspension products without requirement of a PDL prior authorization and continue access to necessary medication for members.
| NDC | Drug Name |
|---|---|
| 00591405094 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 27241017529 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 31722013631 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 59762205801 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 68180028301 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 69238157401 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 70710171604 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 70954016810 | SILDENAFIL 10 MG/ML ORAL SUSP |
| 72205005976 | SILDENAFIL 10 MG/ML ORAL SUSP |